Get started
Author

Peter N. Pferschy

Observed names: P Pferschy, P. Pferschy, PETER N. PFERSCHY, Peter N Pferschy, Peter Nikolaus Pferschy, Peter Pferschy, Pferschy, Peter, Pferschy, Peter N., Pferschy, Peter Nikolaus
ORCID: 0000-0002-7541-553X
Observed ORCID: 0000-0002-7541-553X
OpenAlex ID: A5077137975
Empagliflozin in acute myocardial infarction: the EMMY trial
2022 · Dirk von Lewinski, Ewald Kolesnik, et al. · European Heart Journal · 301
Efficacy and Safety of Intermittent Fasting in People With Insulin-Treated Type 2 Diabetes (INTERFAST-2)—A Randomized Controlled Trial
2022 · Anna Obermayer, Norbert J. Tripolt, et al. · Diabetes Care · 107
Impact of EMpagliflozin on cardiac function and biomarkers of heart failure in patients with acute MYocardial infarction—The EMMY trial
2019 · Norbert J Tripolt, Ewald Kolesnik, et al. · American Heart Journal · 68
Humoral immune response to COVID‐19 vaccination in diabetes is age‐dependent but independent of type of diabetes and glycaemic control: The prospective COVAC‐DM cohort study
2022 · Caren Sourij, Norbert J. Tripolt, et al. · Diabetes Obesity and Metabolism · 66
PDF
Impact of the SGLT2-inhibitor empagliflozin on inflammatory biomarkers after acute myocardial infarction – a post-hoc analysis of the EMMY trial
2023 · Martin Benedikt, Harald Mangge, et al. · Cardiovascular Diabetology · 41
PDF
Impact of physical exercise on sensor performance of the FreeStyle Libre intermittently viewed continuous glucose monitoring system in people with Type 1 diabetes: a randomized crossover trial
2019 · O. Moser, M. L. Eckstein, et al. · Diabetic Medicine · 37
Ertugliflozin to reduce arrhythmic burden in ICD/CRT patients (ERASe-trial) – A phase III study
2022 · Dirk von Lewinski, Norbert J Tripolt, et al. · American Heart Journal · 32
PDF
Impact of COVID-19 Vaccination on Glycemia in Individuals With Type 1 and Type 2 Diabetes: Substudy of the COVAC-DM Study
2021 · Felix Aberer, Othmar Moser, et al. · Diabetes Care · 26
PDF
Pre-Exercise Blood Glucose Levels Determine the Amount of Orally Administered Carbohydrates during Physical Exercise in Individuals with Type 1 Diabetes—A Randomized Cross-Over Trial
2019 · Othmar Moser, Max L. Eckstein, et al. · Nutrients · 26
PDF
Reduction in insulin degludec dosing for multiple exercise sessions improves time spent in euglycaemia in people with type 1 diabetes: A randomized crossover trial
2018 · Othmar Moser, Max L. Eckstein, et al. · Diabetes Obesity and Metabolism · 26
PDF
Timing of SGLT2i initiation after acute myocardial infarction
2023 · Dirk von Lewinski, Ewald Kolesnik, et al. · Cardiovascular Diabetology · 24
PDF
Intermittent Fasting (Alternate Day Fasting) in Healthy, Non-obese Adults: Protocol for a Cohort Trial with an Embedded Randomized Controlled Pilot Trial
2018 · Norbert J. Tripolt, Slaven Stekovic, et al. · Advances in Therapy · 22
PDF
Alteration of circulating platelet-related and diabetes-related microRNAs in individuals with type 2 diabetes mellitus: a stepwise hypoglycaemic clamp study
2022 · Ceren Eyileten, Zofia Wicik, et al. · Cardiovascular Diabetology · 20
PDF
Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL Around Spontaneous Exercise Sessions in Adults with Type 1 Diabetes: A Randomized Cross-Over Trial (ULTRAFLEXI-1 Study)
2022 · Othmar Moser, Alexander Müller, et al. · Diabetes Technology & Therapeutics · 19
Ketone body levels and its associations with cardiac markers following an acute myocardial infarction: a post hoc analysis of the EMMY trial
2024 · Faisal Aziz, Norbert J. Tripolt, et al. · Cardiovascular Diabetology · 18
PDF
Impact of a Single 36 Hours Prolonged Fasting Period in Adults With Type 1 Diabetes – A Cross-Over Controlled Trial
2021 · Othmar Moser, Max L. Eckstein, et al. · Frontiers in Endocrinology · 18
PDF
Hypoglycaemia leads to a delayed increase in platelet and coagulation activation markers in people with type 2 diabetes treated with metformin only: Results from a stepwise hypoglycaemic clamp study
2019 · Felix Aberer, Peter N. Pferschy, et al. · Diabetes Obesity and Metabolism · 18
PDF
Ertugliflozin to Reduce Arrhythmic Burden in Patients with ICDs/CRT-Ds
2024 · Martin Benedikt, Abderrahim Oulhaj, et al. · NEJM Evidence · 17
Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide
2023 · Robert E.J. Ryder, Katharina Laubner, et al. · Diabetes Care · 17
PDF
INTERmittent FASTing in people with insulin‐treated type 2 diabetes mellitus – the INTERFAST‐2 study protocol
2022 · Anna Obermayer, Norbert J. Tripolt, et al. · Diabetic Medicine · 15
PDF
Effects of dietary interventions and intermittent fasting on HDL function in obese individuals with T2DM: a randomized controlled trial
2024 · Anja Pammer, Anna Obermayer, et al. · Cardiovascular Diabetology · 14
PDF
Improved glycaemic variability and basal insulin dose reduction during a running competition in recreationally active adults with type 1 diabetes—A single-centre, prospective, controlled observational study
2020 · Othmar Moser, Alexander Mueller, et al. · PLoS ONE · 14
PDF
Alterations in trimethylamine-N-oxide in response to Empagliflozin therapy: a secondary analysis of the EMMY trial
2023 · Faisal Aziz, Norbert J. Tripolt, et al. · Cardiovascular Diabetology · 13
PDF
Glucose Metabolism and Metabolomic Changes in Response to Prolonged Fasting in Individuals with Obesity, Type 2 Diabetes and Non-Obese People—A Cohort Trial
2023 · Norbert J. Tripolt, Sebastian J. Hofer, et al. · Nutrients · 13
PDF
Feasibility and safety of using an automated decision support system for insulin therapy in the treatment of steroid‐induced hyperglycemia in patients with acute graft‐versus‐host disease: A randomized trial
2018 · Felix Aberer, Julia K Mader, et al. · Journal of Diabetes Investigation · 13
PDF
Works count: 82
Citation count: 1,075
H-index: 17
I10-index: 28
Year
Topic
Type